Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: J Am Coll Surg. 2020 Dec 13;232(4):361–371. doi: 10.1016/j.jamcollsurg.2020.11.017

Table 3:

Tumor Burden of Combined Hepatocellular Carcinoma-Cholangiocarcinoma Tumors Based on Preoperative Imaging

Tumor burden at diagnosis N Received transplant, N (pre-diagnosed as) Received resection, N (Pre-diagnosed as)
Beyond UCSF 48 16 (14 HCC; 1 Indeterminate, 1 Other) 32 (9 iCCA; 12 HCC; 2 cHCC-CCA; 5 Indeterminate; 4 Other)
Beyond Milan, within-UCSF 30 14 (13 HCC; 1 cHCC-CCA) 16 (4 iCCA; 5 HCC; 2 cHCC-CCA; 5 Indeterminate)
Within Milan 122 64 (1 iCCA; 56 HCC; 1 cHCC-CCA; 5 Indeterminate; 1 Other) 58 (9 iCCA; 24 HCC; 5 cHCC-CCA; 16 Indeterminate; 4 Other)
Tumor size/ number details unknown 6 3 (1 HCC; 2 Unknown) 3 (1 iCCA; 1 Indeterminate; 1 Unknown)
Incidental tumor 2 2 0

HCC, hepatocellular carcinoma; iCCA, intrahepatic cholangiocarcinoma; cHCC-CCA, combined hepatocellular-intrahepatic cholangiocarcinoma